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Beta Thalassemia is the most common genetic disorder. The 
disorder is prevalent worldwide. About 3% of the world’s 
population carries the genes for Beta Thalassemia and it is 
estimated that every year about 60000 thalassemic babies 
are born all over the world.1 Approximately 79% of affected 
births are in the Asian population. Carrier rate in Pakistan 
ranges between 5-8%, and around 5000 children are 
diagnosed each year with beta thalassemia in Pakistan.2 
Consanguinity is the main factor leading to high prevalence 
in Pakistan. There are 25,000 children registered with 
thalassemia federation of Pakistan however the actual figure 
is much higher which may be around one lac, as a lot many 
are living in villages that are not registered with any 
thalassemia center.  
The main components of management of thalassemia 
include 1. Conservative management which take into 
account, medical consultation, lab investigations, safe blood 
transfusion, chelation therapy, treatment with HbF 
augmenting agents, 2. Curative management comprising of 
bone marrow transplant and 3. Preventive management 
comprising of thalassemia screening and genetic 
counselling. Accomplishment of ideal management thus 
requires multidisciplinary team addressing all these aspects. 
However, very few centers furnish for all these components 
of optimal thalassemia management under one roof. 
Management of Thalassemia in developing countries like 
Pakistan poses a major challenge. There are more than 40 
Thalassemia centers across the country. Majority of them are 
giving only transfusional support. Government does not 
provide required support and majority of burden is borne by 
NGOs. The main stay of conservative management is blood 
transfusion, iron chelation, management of complications of 
iron overload, and prevention. Frequent blood transfusion 
leads to iron overload requiring treatment with iron 
chelating agent Serum ferritin level vary widely and could 
not be controlled due to poor compliance to chelation. The 
main reason for this noncompliance is the cost of treatment, 
that is beyond the reach of the common man. Majority of 
patients thus have high ferritin level, and present with 
complications of iron overload. Pakistan Baitulmal is 
providing some support in this regard but majority of 
patients remain unaddressed.  
As far as transfusion therapy is concerned, majority of 
centers are trying to fulfil needs of patients but there are 
reservations about screening methods. The well-functioning 
blood bank is of primary importance for the management of 
thalassemia. Its functions are not only to provide the regular 
supply of blood for the treatment of thalassemia, but also to 
ensure supply of safe blood, in order to minimize the risk of 
transfusion-transmitted infections. Various studies have 
shown that 30-40% thalassemics show seropositivity for 
HCV and about 4-6 % become HBV positive, despite the 
availability of vaccine for Hepatitis B.3-5 Though, some 
studies have reported that for the past 10-12 years the better 
screening methods in blood banks in Pakistan have 
significantly reduced the frequency of these diseases. 
Further improvements need to be done to implement 
uniform screening of blood throughout the country.6  
Another big dilemma is that, many of the private centers do 
not have a full time treating physician/clinical hematologist. 
As regards curative aspect, there are very few centers 
(public and private) throughput the country that are offering 
bone marrow transplant and due to high cost, it is out of 
reach of majority of people.  
Regarding preventive aspects, awareness and availability of 
antenatal diagnosis is limited. The main preventive 
strategies for thalassemia include appropriate information of 
the disease and importance of screening through awareness 
programmes, screening and counselling of target families, 
premarital and prenatal screening. Premarital and prenatal 
screening have significantly reduced the prevalence of β 
Thalassemia in various countries as Italy, Greece, Cyprus, 
Iran, and Saudi Arabia with significant reduction in births of 
affected children.7 In Pakistan premarital screening and even 
antenatal screening is almost nonexistent even in urban 
areas. Some hospitals have started with antenatal screening 
and prenatal diagnosis but still due to economic constraints 
most of the couples are underprivileged. 
There is thus a dire need for dedicated thalassemia unit in all 
big hospitals that oversees all aspects of treatment and where 
patients may be referred to the specialists whenever 
required. The centre should offer free medical consultation, 
genetic counselling, specialized pathology investigations, 
safe blood transfusion and chelation therapy to the patients. 
There should be multidisciplinary team comprising of 
Hematologist, Pediatrician, Cardiologist, Endocrinologist, 
Psychiatrist/Psychologist, Social worker and dedicated and 
trained staff. The unit should also try to establish bone 
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marrow transplant unit and offer this facility at minimum 
bearable cost. In nutshell an ideal thalassemia centre should 
have three main units; one dealing with diagnosis and 
treatment, having close liaison with pediatrician, 
endocrinologist, cardiologist, psychologist etc. One unit 
focusing on preventive measures including screening and 
genetic counselling programme and the third one bone 
marrow transplant unit. The centre should also have 
collaboration with national and international organizations. 
The centre should aim at providing greatest possible level of 
comfort and convenience for patients and their families and 
ensure their long and quality life. 
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